| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |